Prognostic implications of serial 18-fluoro-deoxyglucose emission tomography in multiple myeloma treated with total therapy 3. [electronic resource]
Producer: 20130507Description: 1819-23 p. digitalISSN:- 1528-0020
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Biomarkers, Tumor -- analysis
- Bone Neoplasms -- drug therapy
- Clinical Trials as Topic
- Fluorodeoxyglucose F18
- Follow-Up Studies
- Gene Expression Profiling
- Humans
- Magnetic Resonance Imaging
- Multiple Myeloma -- drug therapy
- Multivariate Analysis
- Neoplasm Recurrence, Local -- drug therapy
- Positron-Emission Tomography
- Prognosis
- Radiopharmaceuticals
- Survival Rate
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.